within Pharmacolibrary.Drugs.ATC.G;

model G04BA01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 0.0001,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0006,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G04BA01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Ammonium chloride is an inorganic compound used historically as an expectorant in cough medicine and as a systemic acidifying agent in the treatment of metabolic alkalosis. It is also used to increase urinary acidity for certain medical conditions. Its routine use as a medication is not common in modern clinical practice, and it is not widely approved for therapeutic use globally today.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult humans, as published PK models or direct clinical pharmacokinetic data for ammonium chloride are not available.</p><h4>References</h4><ol><li><p>Holm, M, et al., &amp; van der Linden, J (2019). The MOVEMENT Trial. <i>Journal of the American Heart Association</i> 8(2) e010152–None. DOI:<a href=\"https://doi.org/10.1161/JAHA.118.010152\">10.1161/JAHA.118.010152</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30636504/\">https://pubmed.ncbi.nlm.nih.gov/30636504</a></p></li><li><p>Abebe, BT, et al., &amp; Siegmund, W (2019). Effects of the P-Glycoprotein Inhibitor Clarithromycin on the Pharmacokinetics of Intravenous and Oral Trospium Chloride: A 4-Way Crossover Drug-Drug Interaction Study in Healthy Subjects. <i>Journal of clinical pharmacology</i> 59(10) 1319–1330. DOI:<a href=\"https://doi.org/10.1002/jcph.1421\">10.1002/jcph.1421</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30973998/\">https://pubmed.ncbi.nlm.nih.gov/30973998</a></p></li><li><p>Nilsson, MI, et al., &amp; Anggård, E (1982). Clinical pharmacokinetics of methadone. <i>Acta anaesthesiologica Scandinavica. Supplementum</i> 74 66–69. DOI:<a href=\"https://doi.org/10.1111/j.1399-6576.1982.tb01850.x\">10.1111/j.1399-6576.1982.tb01850.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6953740/\">https://pubmed.ncbi.nlm.nih.gov/6953740</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G04BA01;
